Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.8 HKD | -0.11% | +7.43% | -20.17% |
04-22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
04-22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
ETFs positioned on CanSino Biologics Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.75% | 4 M€ | -27.92% | ||
0.11% | 3 M€ | -0.84% | - | |
0.01% | 35 M€ | -5.85% | - | |
0.01% | 117 M€ | +1.11% | - | |
0.00% | 31 M€ | +3.50% | - | |
0.00% | 34 M€ | +6.71% | - | |
0.00% | 7 M€ | +1.95% | - | |
0.00% | 389 M€ | +6.94% | - | |
0.00% | 39 M€ | +3.67% | - | |
0.00% | 302 M€ | +4.37% | - | |
0.00% | 34 M€ | +2.14% | - | |
0.00% | 17 M€ | +1.44% | - | |
0.00% | 108 M€ | +2.40% | - | |
0.00% | 52 M€ | -0.21% | - | |
0.00% | 8 M€ | -0.60% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.17% | 1.1B | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+56.40% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.99% | 8.71B |
- Stock Market
- Equities
- 6185 Stock
- Funds and ETFs CanSino Biologics Inc.